Working Hours
08045477632
Tirzepatide 12.5 mg Injection is a prescription-based pharmaceutical injectable used for chronic weight management and metabolic support in adults. It belongs to a new generation of therapies known as dual GLP-1 and GIP receptor agonists, designed to help regulate appetite, improve glycemic control, and support sustained weight reduction when combined with proper diet and lifestyle changes.
The 12.5 mg strength is typically part of an advanced dose-escalation regimen, prescribed after lower strengths such as 2.5 mg, 5 mg, 7.5 mg, or 10 mg, depending on patient tolerance and clinical response. This higher dosage is recommended for individuals requiring enhanced therapeutic outcomes under strict medical supervision.
Tirzepatide works by increasing satiety, reducing hunger signals, slowing gastric emptying, and enhancing insulin sensitivity, thereby helping patients manage calorie intake and achieve better metabolic balance.
The injection is usually administered once weekly via subcutaneous route and should only be used as directed by a qualified healthcare professional.
Dual-action GLP-1 & GIP receptor agonist
Higher strength for advanced weight management therapy
Supports appetite control and metabolic regulation
Once-weekly subcutaneous injection
Part of step-up dosage treatment plans
Strength: 12.5 mg
Dosage Form: Injection (Pre-filled pen / vial)
Administration: Subcutaneous
Category: Pharmaceutical Injectables
Storage: Refrigerated (2C 8C)
Prescription: Required (Rx Product)
tirzepatide 12.5 mg injection, weight management injectable, anti obesity injection, GLP-1 GIP agonist injection, tirzepatide supplier india, prescription weight loss injection, tirzepatide dosage
Tirzepatide 12.5 mg injection is used for weight management and metabolic control, especially in patients requiring higher therapeutic doses as prescribed by a doctor.
The 12.5 mg dose is generally prescribed after gradual dose escalation, based on individual response and tolerance to lower doses.
It works by targeting GLP-1 and GIP receptors, helping reduce appetite, improve insulin response, and regulate food intake.
It is administered as a once-weekly subcutaneous injection under medical supervision.
It is a prescription-only medication and should only be used under the guidance of a qualified healthcare professional.
Yes, Tirzepatide injection is an Rx product and requires a valid prescription.
Store in a refrigerator at 2C to 8C, protected from heat and direct light.
Some individuals may experience nausea, reduced appetite, or mild gastrointestinal discomfort. Consult a healthcare professional if symptoms persist.
It should not be used without proper medical consultation and is not suitable for individuals without a prescription.
Disclaimer:
This product information is provided for educational purposes only. Tirzepatide is a prescription medication and should be used strictly under medical supervision.
Price: